Monthly Talks
- This event has passed.
Herpes Cure Pipeline: New Drugs and Vaccines on the Horizon
September 16, 2024 @ 1:00 pm - 2:00 pm EDT
Learn more about the exciting and fast developing field of vaccines for Herpes Simplex Virus.
AGENDA:
- Welcome
- Herpes Vaccines
- Herpes Cure Pipeline
LOCATION:
CDC STI Prevention Conference
Room 203
Online: REGISTER
DETAILED AGENDA
Welcome
- Dr. Jeffrey Klausner: Clinical Professor of Medicine, Population and Public Health Sciences Lead, Infectious Diseases Epidemiology and Applies Studies (I.D.E.A.S.) Initiative Keck School of Medicine of the University of Southern California. Board of Directors, President Herpes Cure Advocacy
Herpes Vaccines
- Dr. Simon Delagrave: Consultant and Owner, DelaGrave Life Sciences. Board of Directors, Herpes Cure Advocacy
Herpes Cure Advocacy is urging the scientific community to develop prophylactic and therapeutic vaccines against herpes simplex virus. Thanks to new technologies invented in the last several years, vaccines are now available against the virus that causes COVID19 and respiratory syncytial virus. However, a vaccine against herpes simplex virus (HSV) remains elusive despite compelling commercial and health economic needs. This talk will give an overview of the latest developments in structural biology, protein design, and other fields, that enable the creation of new vaccine candidates against HSV. Past vaccine discovery efforts as well as ongoing clinical trials will also be discussed. The growing body of knowledge on vaccines and HSV may finally be reaching the threshold of clinical and commercial success.
Promising Updates from Herpes Cure Pipeline
- Dr. Luis Schang: Professor, Cornell University. Board of Directors, Herpes Cure Advocacy. Board of Directors, President, International Society for Antiviral Research